Fusion Antibodies Ltd has today announced a collaboration with the regenerative medicine company Avipero Ltd for humanization of their integrin antibody platform. The antibody engineering and humanization program partnered with Fusion Antibodies relates to the humanization of beta integrin targeting antibodies under development by Avipero for tissue repair and viral infections. The partnership of Avipero […]
Fusion Antibodies will be attending the following events in 2014, we look forward to seeing you there! BioTrinity 2014European Biopartnering and Investment ConferenceLondon, May 12-14 2014 Biotech Outsourcing StrategiesCopenhagen, June 12th 2014 Biotech Outsourcing Strategies 2014Discovery/Early Development & Clinical Outsourcing TracksLondon Royal College of Physicians, 23rd September 2014 BIO-Europe 2014Frankfurt, 3–5 November Antibody Engineering & […]
Fusion Antibodies are today announcing a revision to its service offering for production of Monoclonal Antibodies. With these changes we hope to allow greater flexibility and options to a wider variety of clients and reduce the barriers of entry for the academic and SME market. Fusion Antibodies antibody production services had previously included (as standard) […]
Fusion Antibodies have today announced a partnership with Dutch biotechnology company Pepscan to offer the companies CLIPS epitope mapping platform to Fusion Antibodies Customers. Pepscan is the inventor of epitope mapping with arrays of overlapping linear peptides and has perfected its HiSense linear epitope mapping to deliver unparalleled sensitivity and reproducibility. Unfortunately, the vast majority […]
BizCom Japan, Inc. and Fusion Antibodies Ltd have agreed a Distribution and Marketing Agreement for services and products of Antibody Sequencing and Humanization in Japan. BizCom Japan, Inc., a privately-held Japan-based trading and consulting company, and Fusion Antibodies Ltd, a privately-held, UK-based biotech company, announced today that they have entered into a distribution and marketing […]
The Fusion Antibodies Accelerated Sequencing Technology service will offer an option to researches and SMEs Today we have proudly announced a new, lower-cost, rapid turnaround Antibody Sequencing service. The new F.A.A.S.T (Fusion Antibodies Accelerated Sequencing Technology) service will offer an option to researches and SME’s who may not require the level of detail provided by […]
info@fusionantibodies.com
+44 (0)28 9043 2800
Investor and Media
+44 (0)20 7933 8780
fusion@walbrookpr.com
Fusion Antibodies PLC, Springbank Industrial Estate, 1 Springbank Rd, Dunmurry, Belfast BT17 0QL